VIP Full Form in Medical Terms
In medical and physiology terminology, VIP stands for Vasoactive Intestinal Peptide (also written as Vasoactive Intestinal Polypeptide). It is a 28-amino-acid peptide hormone that acts as both a gut hormone and a neurotransmitter, playing a central role in smooth muscle relaxation, vasodilation, and secretion of water and electrolytes in the gastrointestinal tract.
Key Takeaways
- VIP = Vasoactive Intestinal Peptide, a 28-amino-acid member of the secretin-glucagon peptide family.
- It relaxes GI smooth muscle, dilates blood vessels, and stimulates intestinal secretion.
- Tumors that overproduce VIP are called VIPomas, causing Verner-Morrison (WDHA) syndrome.
- VIP acts through two receptors, VPAC1 and VPAC2.
- A separate, non-hormonal use of “VIP” exists in hospitals — Very Important Patient — an administrative term, not a physiological one.
What Does VIP Stand For in Medicine?
VIP was first isolated from porcine small intestine in 1970 and has since been found throughout the body — in the brain, respiratory tract, exocrine glands, and peripheral nervous system. Despite its name referencing the “intestine,” VIP’s actions extend well beyond the gut.
The peptide belongs to the secretin family, which also includes secretin, glucagon, gastric inhibitory peptide (GIP), and PACAP (pituitary adenylate cyclase-activating peptide). This shared ancestry explains why several of these hormones have overlapping receptor-binding behavior.
Disambiguation: The Different Meanings of “VIP” in Medical Contexts
| Expansion | Field | What It Refers To |
|---|---|---|
| Vasoactive Intestinal Peptide | Physiology / Endocrinology | Gut hormone and neurotransmitter regulating smooth muscle, secretion, and vasodilation |
| VIPoma | Oncology | Neuroendocrine tumor secreting excess VIP (name derived from VIP, not a separate expansion) |
| Very Important Patient | Hospital administration | A patient designation for high-profile individuals requiring extra privacy/security — unrelated to the hormone |
For NEET, MBBS, and nursing exams, Vasoactive Intestinal Peptide is the expansion you need to know.
Physiological Functions of VIP
| System/Organ | Effect of VIP |
|---|---|
| Blood vessels | Potent vasodilation, reduces peripheral resistance |
| GI smooth muscle | Relaxation (including lower esophageal sphincter) |
| Pancreas | Stimulates bicarbonate and electrolyte secretion |
| Respiratory tract | Bronchodilation |
| Immune system | Modulates Th1/Th2 balance, anti-inflammatory effects |
| CNS | Acts as a neurotransmitter, involved in circadian rhythm regulation |
VIP has a very short half-life — roughly two minutes in circulation — which is why its effects are typically local and short-lived rather than systemic and prolonged.
VIP Receptors: VPAC1 and VPAC2
VIP exerts its effects by binding two G-protein-coupled receptors:
- VPAC1 — widely expressed, mediates most GI and vascular effects.
- VPAC2 — expressed in smooth muscle, the suprachiasmatic nucleus (circadian regulation), and implicated in cancer cell migration when overexpressed.
Both receptors signal primarily through the cyclic AMP (cAMP) pathway.
Clinical Significance: VIPoma and Verner-Morrison Syndrome
A VIPoma is a rare neuroendocrine tumor — usually arising from pancreatic islet cells — that autonomously secretes large amounts of VIP. First described by Verner and Morrison in 1958, the resulting clinical picture is remembered by the mnemonic WDHA syndrome:
- Watery diarrhea (often profuse, 3–8 litres/day)
- Dehydration
- Hypokalemia
- Achlorhydria
VIPoma is extremely rare, with an estimated incidence of about 1 in 10,000,000 people annually. Roughly 90% originate in the pancreas, and about two-thirds are malignant at diagnosis. Diagnosis involves demonstrating elevated serum VIP alongside imaging to localize the tumor; treatment combines surgical resection with somatostatin analogues such as octreotide to control symptoms.
VIP vs Other GI Hormones — Quick Comparison
| Hormone | Primary Source | Key Action |
|---|---|---|
| VIP | Neurons of GI tract, pancreas | Smooth muscle relaxation, vasodilation, secretion |
| Secretin | S cells, duodenum | Stimulates pancreatic bicarbonate secretion |
| Gastrin | G cells, stomach antrum | Stimulates gastric acid secretion |
| CCK (Cholecystokinin) | I cells, duodenum/jejunum | Gallbladder contraction, pancreatic enzyme release |
| GIP | K cells, duodenum | Insulin release, inhibits gastric acid |
NEET / MBBS High-Yield Exam Box
- VIP is a member of the secretin-glucagon peptide family.
- VIP receptor signaling works via cAMP, not IP3/calcium.
- VIPoma = Verner-Morrison syndrome = WDHA syndrome — a classic exam link.
- VIP causes hypokalemia and achlorhydria, unlike most secretory diarrheas.
- Half-life of VIP in blood is approximately 2 minutes.
- Do not confuse the hormone VIP with the hospital-administration term “Very Important Patient” — exam questions test the former.
Frequently Asked Questions
What is the full form of VIP in medical terms?
VIP stands for Vasoactive Intestinal Peptide, a 28-amino-acid gut hormone and neurotransmitter that relaxes smooth muscle and stimulates intestinal secretion.
What is the difference between VIP and VIPoma?
VIP is the hormone itself; a VIPoma is a rare pancreatic neuroendocrine tumor that secretes excessive amounts of VIP, causing Verner-Morrison syndrome.
Which receptors does VIP act on?
VIP binds two G-protein-coupled receptors, VPAC1 and VPAC2, both of which signal mainly through the cAMP pathway.
What symptoms does VIPoma cause?
VIPoma classically causes the WDHA syndrome — watery diarrhea, dehydration, hypokalemia, and achlorhydria — due to unregulated VIP secretion.
Is VIP related to secretin?
Yes. VIP belongs to the secretin-glucagon family of peptide hormones, which also includes glucagon and gastric inhibitory peptide (GIP).
Does “VIP” ever mean something non-hormonal in hospitals?
Yes — hospitals sometimes use “VIP” informally to mean “Very Important Patient,” an administrative designation unrelated to the physiological hormone and not typically tested in medical exams.
